/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749804786&Signature=E6Koj7rGk1xibA3B~Tz7wPQ3FsHPY~uGCYOsLI~cTIzSzRh6Mzuk7G7BHqsT4q4KmwL0ilCEhcZGn8DG9ELcKf84MB31J3KjihF2pRAMyDFbfmNchzetsJ9vbPpoVCZ8iBTpFk8p1iWKgF1tXsQWTWkuBrB2z-2gCx1FO7ElzHqHirIw2KBAe9xgzman7nqBMUvg9A4zbOtNsZJPkXFCG5gaemakleFTfeP70IZDYI1xKqE41tL5-yXmuNzDNl~74-gv9Vy5zyoRe0JboGfgC7qaNNGj5GiSJ5yhtCsECUv6bk-LpeE3z~52mMpmkLwzrQABPTuS7ubTuNQYQdisow__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ectin Research AB | Sweden | ECTIN B | |
|
Elanix Biotechnologies AG | Germany | ELN | |
|
Elbit Meditec-M Ltd. | Israel | EMTC-M | |
|
Elicera Therapeutics AB | Sweden | ELIC | |
|
Elron Ventures Ltd. | Israel | ELRN | |
|
Enlivex Therapeutics Ltd. | Israel | ENLV | |
|
ERYTECH Pharma S.A. | France | ERYP | |
|
Eurobio Scientific | France | ALERS | |
|
EUROESPES | Spain | EEP | |
|
European Institute of Science AB | Sweden | EURI B |